Akèy › Amiloidoz › Maryland › Baltimore
Etid klinik pou Amiloidoz nan Baltimore, MD
6 etid pou Amiloidoz ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Ap rekriteEtid obsèvasyon
- Research Site, Baltimore
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Ap rekriteFaz 3
- Clinical Trial Site, Baltimore
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Ap rekriteFaz 3
- Clinical Trial Site, Baltimore
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Ap rekriteEtid obsèvasyon
- Clinical Trial Site, Baltimore
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Ap rekriteFaz 3
- University of Maryland Medical Center, Baltimore
- Johns Hopkins University, Baltimore
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Ap rekriteFaz 3
- Johns Hopkins University, Baltimore
Etid Amiloidoz nan lòt vil
- Boston, MA11 etid
- Rochester, MN10 etid
- New York City, NY10 etid
- Dallas, TX9 etid
- Philadelphia, PA7 etid
- Houston, TX6 etid
- Durham, NC6 etid
- Portland, OR6 etid
- St. Louis, MO6 etid
- San Diego, CA5 etid
- Cleveland, OH5 etid
- Chicago, IL5 etid
Lòt etid nan Baltimore
- Kansè Poumon ki pa ti selil60 etid
- Kansè nan tete47 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Kansè (tout kalite)37 etid
- Kansè kolorektal31 etid
- Kansè pankreyas31 etid
- Kansè Metastatik28 etid
- Obèsite25 etid
- Ensifizyans kadyak24 etid
- Kansè vejik24 etid
- Akidan serebavaskilè22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.